Hostname: page-component-78c5997874-ndw9j Total loading time: 0 Render date: 2024-11-10T15:08:02.675Z Has data issue: false hasContentIssue false
  • English
  • Français

Trends in the psychopharmacological treatment of bipolar disorder: a nationwide register-based study

Published online by Cambridge University Press:  11 September 2015

Louise Bjørklund Open the ORCID record for Louise Bjørklund [Opens in a new window] ,
Henriette Thisted Horsdal ,
Ole Mors ,
Søren Dinesen Østergaard  and
Christiane Gasse
Louise Bjørklund*
Affiliation:
Research Department P, Aarhus University Hospital, Risskov, Denmark
Henriette Thisted Horsdal
Affiliation:
National Centre for Register-based Research, Aarhus University, Aarhus, Denmark
Ole Mors
Affiliation:
Research Department P, Aarhus University Hospital, Risskov, Denmark The Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark Centre for Integrated Register-Based Research at Aarhus University (CIRRAU), Aarhus, Denmark
Søren Dinesen Østergaard
Affiliation:
Research Department P, Aarhus University Hospital, Risskov, Denmark The Initiative for Integrative Psychiatric Research (iPSYCH), Aarhus, Denmark Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
Christiane Gasse
Affiliation:
National Centre for Register-based Research, Aarhus University, Aarhus, Denmark
*
Louise Bjørklund, Research Department P, Aarhus University Hospital, Risskov, Denmark. Tel: +45 41697948; Fax: +45 78471609; E-mail: louibjoe@rm.dk
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective

In bipolar disorder, treatment with antidepressants without concomitant use of mood stabilisers (antidepressant monotherapy) is associated with development of mania and rapid cycling and is therefore not recommended. The present study aimed to investigate the psychopharmacological treatment patterns in bipolar disorder over time, with a focus on antidepressant monotherapy.

Methods

Cohort study with annual cross-sectional assessment of the use of psychotropic medications between 1995 and 2012 for all Danish residents aged 10 years or older with a diagnosis of bipolar disorder registered in the Danish Psychiatric Central Research Register. Users of a given psychotropic medication were defined as individuals having filled at least one prescription for that particular medication in the year of interest.

Results

We identified 20 618 individuals with bipolar disorder. The proportion of patients with bipolar disorder using antidepressants, atypical antipsychotics and anticonvulsants increased over the study period, while the proportion of patients using lithium, typical antipsychotics and benzodiazepines/sedatives decreased. The proportion of patients treated with antidepressant monotherapy decreased from 20.5% in 1997 to 12.1% in 2012, and among antidepressant users, the proportion in monotherapy decreased from 47.7% to 23.9%, primarily driven by a decrease in the use of tricyclic antidepressants.

Conclusion

The results show an increase in the proportion of patients with bipolar disorder being treated with antidepressants in the period from 1997 to 2012. However, in accordance with international treatment guidelines, the extent of antidepressant monotherapy decreased during the same period.

Keywords

antidepressantsbipolar disordermood stabiliserspsychopharmacology
Type
Original Articles
Information
Acta Neuropsychiatrica , Volume 28 , Issue 2 , April 2016 , pp. 75 - 84
Check for updates
Copyright
© Scandinavian College of Neuropsychopharmacology 2015 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Vieta, E, Valenti, M. Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis. CNS Drugs 2013;27:515–529.CrossRefGoogle ScholarPubMed
2. Kupka, RW, Altshuler, LL, Nolen, WA et al. Three times more days depressed than manic or hypomanic in both bipolar I and bipolar II disorder. Bipolar Disord 2007;9:531–535.Google Scholar
3. Viktorin, A, Lichtenstein, P, Thase, ME et al. The risk of switch to mania in patients with bipolar disorder during treatment with an antidepressant alone and in combination with a mood stabilizer. Am J Psychiatry 2014;171:1067–1073.Google Scholar
4. Carlborg, A, Ferntoft, L, Thuresson, M, Bodegard, J. Population study of disease burden, management, and treatment of bipolar disorder in Sweden: a retrospective observational registry study. Bipolar Disord 2015;17:76–85.CrossRefGoogle ScholarPubMed
5. Bauer, M, Ritter, P, Grunze, H, Pfennig, A. Treatment options for acute depression in bipolar disorder. Bipolar Disord 2012;14(Suppl. 2):37–50.Google Scholar
6. Sidor, MM, MacQueen, GM. An update on antidepressant use in bipolar depression. Curr Psychiatry Rep 2012;14:696–704.Google Scholar
7. Kessing, LV, Hellmund, G, Geddes, JR, Goodwin, GM, Andersen, PK. Valproate v. lithium in the treatment of bipolar disorder in clinical practice: observational nationwide register-based cohort study. Br J Psychiatry 2011;199:57–63.Google Scholar
8. Grunze, H, Vieta, E, Goodwin, GM et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2012 on the long-term treatment of bipolar disorder. World J Biol Psychiatry 2013;14:154–219.Google Scholar
9. Hayes, J, Prah, P, Nazareth, I et al. Prescribing trends in bipolar disorder: cohort study in the United Kingdom THIN primary care database 1995–2009. PLoS One 2011;6:e28725.Google Scholar
10. Sundhedsstyrelsen. Kommissorium for udarbejelse af nationale kliniske retningslinjer for medicinsk behandling af bipolar lidelse (maniodepressiv sygdom) 2013. Copenhagen (in Danish).Google Scholar
11. Sundhedsstyrelsen. National klinisk retningslinje for farmakologisk behandling af bipolar lidelse - supplerende vedligeholdelsesbehandling efter depression 2014. Copenhagen (in Danish).Google Scholar
12. Goodwin, GM. Consensus group of the British Association for Psychopharmacology. Evidence-based guidelines for treating bipolar disorder: revised second edition – recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2009;23:346–388.CrossRefGoogle Scholar
13. Thase, ME. Bipolar depression: diagnostic and treatment considerations. Dev Psychopathol 2006;18:1213–1230.CrossRefGoogle ScholarPubMed
14. Pacchiarotti, I, Bond, DJ, Baldessarini, RJ et al. The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders. Am J Psychiatry 2013;170:1249–1262.Google Scholar
15. Licht, RW, Gijsman, H, Nolen, WA, Angst, J. Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce switch into mania or cycle acceleration. Acta Psychiatr Scand 2008;118:337–346.CrossRefGoogle ScholarPubMed
16. Grunze, H, Vieta, E, Goodwin, GM et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry 2010;11:81–109.Google Scholar
17. Baldessarini, RJ, Leahy, L, Arcona, S, Gause, D, Zhang, W, Hennen, J. Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders. Psychiatr Serv 2007;58:85–91.CrossRefGoogle ScholarPubMed
18. Greil, W, Haberle, A, Haueis, P, Grohmann, R, Russmann, S. Pharmacotherapeutic trends in 2231 psychiatric inpatients with bipolar depression from the International AMSP Project between 1994 and 2009. J Affect Disord 2012;136:534–542.Google Scholar
19. Baek, JH, Ha, K, Yatham, LN et al. Pattern of pharmacotherapy by episode types for patients with bipolar disorders and its concordance with treatment guidelines. J Clin Psychopharmacol 2014;34:577–587.Google Scholar
20. Thygesen, LC, Daasnes, C, Thaulow, I, Bronnum-Hansen, H. Introduction to Danish (nationwide) registers on health and social issues: structure, access, legislation, and archiving. Scand J Public Health 2011;39(Suppl. 7):12–16.CrossRefGoogle ScholarPubMed
21. Pedersen, CB, Gotzsche, H, Moller, JO, Mortensen, PB. The Danish civil registration system. A cohort of eight million persons. Dan Med Bull 2006;53:441–449.Google ScholarPubMed
22. Mors, O, Perto, GP, Mortensen, PB. The Danish psychiatric central research register. Scand J Public Health 2011;39(Suppl. 7):54–57.Google Scholar
23. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders. Diagnostic Criteria for Research, Geneva. 1993.Google Scholar
24. Kildemoes, HW, Sorensen, HT, Hallas, J. The Danish national prescription registry. Scand J Public Health 2011;39(Suppl. 7):38–41.Google Scholar
25. Medici, CR, Videbech, P, Gustafsson, LN, Munk-Jorgensen, P. Mortality and secular trend in the incidence of bipolar disorder. J Affect Disord 2015;183:39–44.CrossRefGoogle ScholarPubMed
26. Kristiansen, CB, Shanmuganathan, JW, Gustafsson, LN, Lokke, KP, Munk-Jorgensen, P. Increasing incidence and diagnostic instability in adult attention-deficit hyperactivity disorder nationwide between 1995 and 2012. Atten Defic Hyperact Disord 2015;7:151–156.Google Scholar
27. Baldessarini, RJ, Tondo, L, Vazquez, GH et al. Age at onset versus family history and clinical outcomes in 1,665 international bipolar-I disorder patients. World Psychiatry 2012;11:40–46.CrossRefGoogle Scholar
28. Grant, BF, Stinson, FS, Hasin, DS et al. Prevalence, correlates, and comorbidity of bipolar I disorder and axis I and II disorders: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 2005;66:1205–1215.Google Scholar
29. Ghaemi, SN, Boiman, EE, Goodwin, FK. Diagnosing bipolar disorder and the effect of antidepressants: a naturalistic study. J Clin Psychiatry 2000;61:804–808. quiz 809.Google Scholar
30. Ostergaard, SD, Bertelsen, A, Nielsen, J, Mors, O, Petrides, G. The association between psychotic mania, psychotic depression and mixed affective episodes among 14,529 patients with bipolar disorder. J Affect Disord 2013;147:44–50.CrossRefGoogle Scholar
31. Berk, M, Dodd, S, Callaly, P et al. History of illness prior to a diagnosis of bipolar disorder or schizoaffective disorder. J Affect Disord 2007;103:181–186.Google Scholar
32. Pedersen, CB, Mors, O, Bertelsen, A et al. A comprehensive nationwide study of the incidence rate and lifetime risk for treated mental disorders. JAMA Psychiatry 2014;71:573–581.CrossRefGoogle ScholarPubMed
33. Kroon, JS, Wohlfarth, TD, Dieleman, J et al. Incidence rates and risk factors of bipolar disorder in the general population: a population-based cohort study. Bipolar Disord 2013;15:306–313.CrossRefGoogle ScholarPubMed
34. Russo, P, Smith, MW, Dirani, R, Namjoshi, M, Tohen, M. Pharmacotherapy patterns in the treatment of bipolar disorder. Bipolar Disord 2002;4:366–377.CrossRefGoogle ScholarPubMed
35. Hardoon, S, Hayes, JF, Blackburn, R et al. Recording of severe mental illness in United Kingdom primary care, 2000-2010. PLoS One 2013;8:e82365.CrossRefGoogle ScholarPubMed
36. Diflorio, A, Jones, I. Is sex important? Gender differences in bipolar disorder. Int Rev Psychiatry 2010;22:437–452.Google Scholar
37. Grunze, H, Vieta, E, Goodwin, GM et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry 2009;10:85–116.Google Scholar
38. Nierenberg, AA, Ostergaard, SD, Iovieno, N, Walker, RS, Fava, M, Papakostas, GI. Predictors of placebo response in bipolar depression. Int Clin Psychopharmacol 2015;30:59–66.CrossRefGoogle ScholarPubMed
39. Post, RM, Ketter, TA, Pazzaglia, PJ et al. Rational polypharmacy in the bipolar affective disorders. Epilepsy Res Suppl 1996;11:153–180.Google Scholar
40. Munk-Jorgensen, P, Ostergaard, SD. Register-based studies of mental disorders. Scand J Public Health 2011;39(Suppl. 7):170–174.Google Scholar
41. Bock, C, Bukh, JD, Vinberg, M, Gether, U, Kessing, LV. Validity of the diagnosis of a single depressive episode in a case register. Clin Pract Epidemiol Ment Health 2009;5:1–8.Google Scholar
42. Kessing, L. Validity of diagnoses and other clinical register data in patients with affective disorder. Eur Psychiatry 1998;13:392–398.Google Scholar
43. Uggerby, P, Ostergaard, SD, Roge, R, Correll, CU, Nielsen, J. The validity of the schizophrenia diagnosis in the Danish psychiatric central research register is good. Dan Med J 2013;60:A4578.Google Scholar
44. Oliveros, JC. An interactive tool for comparing lists with Venn’s diagrams. Available at http://bioinfogp.cnb.csic.es/tools/venny/index.html. Accessed August 2015.Google Scholar